Bias in Associations of Emerging Biomarkers With Cardiovascular Disease

Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke

Biomarkers of Cardiovascular Disease

Associations of subclinical cardiovascular disease with frailty.

BACKGROUND Frail health in old age has been conceptualized as a loss of physiologic reserve associated with loss of lean mass, neuroendocrine dysregulation, and immune dysfunction. Little work has been done to define frailty and describe the underlying pathophysiology. METHODS Frailty status was defined in participants of the Cardiovascular Health Study (CHS), a cohort of 5,201 community-dwel...

effects of soy on metabolic biomarkers of cardiovascular disease in elderly women with the metabolic syndrome

objective: to ascertain the effects of soy [in the forms of textured soy protein (tsp) and soy-nut] on lipid profiles, apolipoproteins, inflammatory and prothrombotic markers and blood pressure in elderly women with the metabolic syndrome. materials and methods: the study is a 12-week parallel randomized controlled trial that was conducted in rural health centres of babol, iran. the participant...

Circulating Biomarkers in Cardiovascular Disease

According to the Merriam-Webster Online Dictionary, a biomarker is ‘a distinctive biological or biologically derived indicator (as a metabolite) of a process, event, or condition (as aging, disease, or oil formation)’ [1]. A biomarker can be structural, such as mammography or a coronary calcium scan, or functional, such as glomerular filtration rate or blood pressure, but the term biomarker is ...